GHK-Cu Peptide

Evidence

GHK-Cu peptide benefits: what was measured, and in what

Popular GHK-Cu benefit claims traced to the studies behind them: which used cells, animals or people, which were controlled, and which were null.

By the GHK-Cu Peptide editorial team · Last reviewed · Editorial review: pending

Short answer

No benefit of GHK-Cu has been established in people. Three randomised trials of topical products are indexed: two found no objective difference from the comparison[Bishop 1992] [Miller 2006] and one reported faster ulcer closure [Mulder 1994]. Most other findings come from cells and animals, and a 2026 evidence map concluded that the clinical evidence remains sparse [Mateescu 2026].

Topic by topic: what was measured

GHK-Cu findings by topic, with model and evidence grade
TopicWhat was measuredModel and routeReported resultGrade
Skin appearance after laser resurfacingRedness, wrinkles and overall quality on objective and blinded assessment; patient satisfactionPeople, topical, randomised, 13 completersNo objective difference; patient-reported satisfaction differed [Miller 2006]Evidence grade A
Chronic venous leg ulcersUlcer size vs silver sulfadiazine and vehicle placeboPeople, topical 0.4% cream, randomised, 86 evaluableNo difference from placebo [Bishop 1992]Evidence grade A
Neuropathic plantar ulcersUlcer area closure vs vehiclePeople, topical gel, randomised, size not in abstractGreater median closure reported; not independently replicated [Mulder 1994]Evidence grade A
Hair countsHair count, length, thicknessPeople, a 5-ALA–GHK complex (not GHK-Cu) vs placebo, 45 menCount differed in one dose group; length and thickness did not [Lee 2016]Evidence grade B
Hair regrowth with injected formulationsRegrowth and adverse eventsPeople, uncontrolled, six or more activesCannot be attributed to copper tripeptide-1 [Kapoor 2018]Evidence grade B
Collagen productionCollagen synthesis by fibroblastsCell cultureIncrease peaking at 10⁻⁹ M in culture [Maquart 1988]Evidence grade D
Connective tissue in woundsCollagen, DNA and glycosaminoglycans in implanted chambersRats, material injected into an implanted chamberConcentration-dependent increases vs saline [Maquart 1993]Evidence grade C
Skin penetrationCopper crossing and retained in excised human skinExcised skin, no person exposedCopper measured, not intact peptide [Hostynek 2010]Evidence grade D

Why the human results disagree

The three randomised trials tested different topical products, in different groups of people, decades apart. The 1992 trial compared a 0.4% copper tripeptide cream with silver sulfadiazine and a placebo; silver sulfadiazine reduced ulcer size and the copper tripeptide cream did not differ from placebo [Bishop 1992]. The 1994 trial, which gave its gel immediately after debridement within a standardised care protocol, reported greater closure than vehicle [Mulder 1994]. The 2006 trial measured recovery after laser resurfacing and found no objective difference [Miller 2006]. None has been independently replicated, and a 2025 review noted a “surprising absence” of clinical studies of the GHK-Cu and palmitoyl-GHK used in cosmetic products [Mortazavi 2025].

Laboratory findings and their limits

  • Cell studies report changes in collagen [Maquart 1988] and matrix enzymes [Siméon 2000] at nanomolar concentrations. In the enzyme study, copper ions alone reproduced the effect and GHK alone did not [Siméon 2000], so copper itself is a confounder.
  • Animal studies disagree with each other: rat wound chambers [Maquart 1993] and rabbit wounds [Cangul 2006] showed changes in the measured direction, a guinea-pig study observed slower skin reorganisation [Buffoni 1995], and an irradiated rat-flap study measured a larger ischaemic area with the GHK-Cu gel than with the control[Parker 2013].
  • Skin penetration has been measured as copper crossing excised skin, not as intact peptide [Hostynek 2010].

Who wrote the positive summaries

Three widely cited narrative reviews list Skin Biology, a commercial skin-care company, as their authors’ affiliation [Pickart 2008] [Pickart 2015] [Pickart 2018]. Their findings are not wrong for that reason, but they are not systematic reviews and they rely heavily on cell and animal data. More recent systematic and critical reviews reach more cautious conclusions [Mateescu 2026] [Yi 2026], and a 2026 letter disputed a review’s weighting of mechanism against clinical evidence [Rahman 2026] [Mokhtar 2026].

To check any claim yourself, filter the evidence explorer by model and route, and read the grading method. Safety data are covered separately on the side effects page.

Frequently asked questions

Has any GHK-Cu benefit been proven?

No benefit of GHK-Cu has been established in people. The human evidence is three small randomised trials of topical products with mixed results, plus uncontrolled studies of multi-ingredient products. Most positive findings come from cells and animals.

Why do so many sources describe GHK-Cu so positively?

Many summaries rely on cell and animal results, and several of the most-cited reviews list a commercial skin-care company as the authors’ affiliation. A 2026 letter in Aesthetic Surgery Journal argued that mechanistic plausibility should not be conflated with clinical validation.

Do topical findings apply to other routes?

No. The only randomised human data are for topical products. They say nothing about any other route, and FDA has flagged injectable GHK-Cu as a compounding safety risk.

References

  1. Bishop JB, Phillips LG, Mustoe TA et al. (1992). A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg. PubMed 1495150 · doi:10.1067/mva.1992.37086[Human, grade A]
  2. Mulder GD, Patt LM, Sanders L et al. (1994). Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. PubMed 17147644 · doi:10.1046/j.1524-475X.1994.20406.x[Human, grade A]
  3. Miller TR, Wagner JD, Baack BR et al. (2006). Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. PubMed 16847171 · doi:10.1001/archfaci.8.4.252[Human, grade A]
  4. Lee WJ, Sim HB, Jang YH et al. (2016). Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth. Ann Dermatol. PubMed 27489425 · doi:10.5021/ad.2016.28.4.438[Human, grade B]
  5. Kapoor R, Shome D (2018). Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study. J Cosmet Laser Ther. PubMed 29482481 · doi:10.1080/14764172.2018.1439965[Human, grade B]
  6. Maquart FX, Pickart L, Laurent M et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. PubMed 3169264 · doi:10.1016/0014-5793(88)80509-x[In vitro, grade D]
  7. Maquart FX, Bellon G, Chaqour B et al. (1993). In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. PubMed 8227353 · doi:10.1172/JCI116842[Animal, grade C]
  8. Siméon A, Emonard H, Hornebeck W et al. (2000). The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. PubMed 11045606 · doi:10.1016/s0024-3205(00)00803-1[In vitro, grade D]
  9. Hostynek JJ, Dreher F, Maibach HI (2010). Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy. Inflamm Res. PubMed 20703511 · doi:10.1007/s00011-010-0214-4[Ex vivo, grade D]
  10. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR (2025). Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. Bioimpacts. PubMed 39963574 · doi:10.34172/bi.30071[Review, grade R]
  11. Mateescu DM, Gavrilescu DM, Mincioaga RI et al. (2026). GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap. Pharmaceutics. PubMed 42797253 · doi:10.3390/pharmaceutics18091077[Review, grade R]
  12. Mokhtar J, Mohamad B, Haddad J et al. (2026). The Regenerative Potential of GHK-Cu in Aesthetic Medicine. Aesthet Surg J. PubMed 42619529 · doi:10.1093/asj/sjag169[Review, grade R]
  13. Rahman E, Webb WR (2026). Mechanistic Plausibility Should not be Conflated With Clinical Validation of Glycyl-L-Histidyl-L-Lysine-Copper. Aesthet Surg J. PubMed 42981269 · doi:10.1093/asj/sjag227[Review, grade R]
  14. Yi KH, Kim HS, Lee HE et al. (2026). Peptides in Aesthetic Dermatology: Classification, Fibroblast-Centered Mechanisms, Delivery Technologies, and Clinical Evidence. Life (Basel). PubMed 42942246 · doi:10.3390/life16101660[Review, grade R]
  15. Pickart L (2008). The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. PubMed 18644225 · doi:10.1163/156856208784909435[Review, grade R]
  16. Pickart L, Vasquez-Soltero JM, Margolina A (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. PubMed 26236730 · doi:10.1155/2015/648108[Review, grade R]
  17. Pickart L, Margolina A (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. PubMed 29986520 · doi:10.3390/ijms19071987[Review, grade R]
  18. Parker NP, Ardeshirpour F, Schmechel SC et al. (2013). Effects of topical copper tripeptide complex on wound healing in an irradiated rat model. Otolaryngol Head Neck Surg. PubMed 23744835 · doi:10.1177/0194599813492644[Animal, grade C]
  19. Buffoni F, Pino R, Dal Pozzo A (1995). Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Arch Int Pharmacodyn Ther. PubMed 8836453[Animal, grade C]
  20. Cangul IT, Gul NY, Topal A et al. (2006). Evaluation of the effects of topical tripeptide-copper complex and zinc oxide on open-wound healing in rabbits. Vet Dermatol. PubMed 17083573 · doi:10.1111/j.1365-3164.2006.00551.x[Animal, grade C]